329 related articles for article (PubMed ID: 19893469)
1. New perspectives in medical approach to therapy of head and neck squamous cell carcinoma.
Santarelli A; Lo Russo L; Bambini F; Campisi G; Lo Muzio L
Minerva Stomatol; 2009 Sep; 58(9):445-52. PubMed ID: 19893469
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma.
Krstevska V
J BUON; 2009; 14(3):361-73. PubMed ID: 19810125
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for head and neck cancer: latest developments and future perspectives.
Bernier J; Bentzen SM
Curr Opin Oncol; 2006 May; 18(3):240-6. PubMed ID: 16552235
[TBL] [Abstract][Full Text] [Related]
5. Expanding role of the medical oncologist in the management of head and neck cancer.
Choong N; Vokes E
CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
[TBL] [Abstract][Full Text] [Related]
6. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
Murdoch D
Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
[TBL] [Abstract][Full Text] [Related]
7. [Development of treatments for head and neck squamous cell carcinomas].
Tsukuda M
Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():85-96. PubMed ID: 10410663
[TBL] [Abstract][Full Text] [Related]
8. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
Bernier J; Cooper JS
Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
Bourhis J; Lefebvre JL; Vermorken JB
Eur J Cancer; 2010 Jul; 46(11):1979-89. PubMed ID: 20561781
[TBL] [Abstract][Full Text] [Related]
11. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
[TBL] [Abstract][Full Text] [Related]
12. Concurrent chemotherapy and radiotherapy for head and neck cancer.
Burri RJ; Lee NY
Expert Rev Anticancer Ther; 2009 Mar; 9(3):293-302. PubMed ID: 19275508
[TBL] [Abstract][Full Text] [Related]
13. Emerging drugs for head and neck cancer.
Rhee JC; Khuri FR; Shin DM
Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in head and neck cancer: current practice and future possibilities.
Agada FO; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations.
Martinez JC; Otley CC; Okuno SH; Foote RL; Kasperbauer JL
Dermatol Surg; 2004 Apr; 30(4 Pt 2):679-86. PubMed ID: 15061855
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents.
Caponigro F; Milano A; Basile M; Ionna F; Iaffaioli RV
Curr Opin Oncol; 2006 May; 18(3):247-52. PubMed ID: 16552236
[TBL] [Abstract][Full Text] [Related]
18. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
Horiuchi M; Tamura Y; Miyake H
Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions.
Shin DM; Lippman SM
Semin Oncol; 1999 Feb; 26(1 Suppl 2):100-5. PubMed ID: 10190789
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]